Drugs / Influenza Split Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01554826 | Mar → May 2009 | influenza | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Split Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01554826 ↗ |
| Modality | Vaccine | “Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)” NCT01554826 ↗ |